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Abstract
Background: Many medical research projects encounter difficulties. The objective of this study was to assess the
self-reported frequency of difficulties encountered by medical researchers while conducting research and to identify
factors associated with their occurrence.
Methods: The authors conducted a cross-sectional survey in 2010 among principal investigators of 996 study
protocols approved by the Research Ethics Committee in Geneva, Switzerland, between 2001 and 2005. The authors
asked principal investigators to rate the level of difficulty (1: none, to 5: very great) encountered across the research
process.
Results: 588 questionnaires were sent back (participation rate 59.0 %). 391 (66.5 %) studies were completed at the
time of the survey. Investigators reported that the most frequent difficulties were related to patient enrollment
(44.3 %), data collection (26.7 %), data analysis and interpretation (21.5 %), collaboration with caregivers (21.0 %),
study design (20.4 %), publication in peer-reviewed journal (20.2 %), hiring of competent study personnel (20.2 %),
and getting funding (19.2 %). On average, investigators reported 2.8 difficulties per project (SD 2.8, range 0 to 12).
In multivariable analysis, the number of difficulties was higher for studies initiated by public sponsors (vs. private),
single center studies (vs. multicenter), and studies about treatment, diagnosis or prognosis (i.e., clinical vs. other
studies).
Conclusions: Medical researchers reported substantial logistical difficulties in conducting clinical research.
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Background
Evidence-based medicine [1] and clinical research are
positively valued by health care professionals [2–5],
many of whom engage in research [6–9] alongside their
clinical activity, in many countries [7, 8] and in
Switzerland [6]. Research is necessary to improve med-
ical knowledge, and medical (or clinical) researchers pur-
suing an academic career have the incentive to publish
their results so as to obtain credit from their peers and
institutions. However, time devoted to research is gener-
ally scarce [9, 10] because clinical activity has priority.
Furthermore, medical researchers report moderate levels
of research skills [9, 11, 12]. As a result, the numbers of
medical researchers [13, 14] and the number of applica-
tions for scientific career awards and for research
funding have been decreasing over the past three de-
cades, notably in the United States, Finland and Sweden
[15–17]. This gap between the necessity of medical re-
search and the limited ability of doctors to actually con-
duct medical research suggests the need to better
understand the difficulties encountered by medical
researchers.
Several difficulties in conducting clinical research have
been already reported. Challenges include designing the
study, calculating the adequate sample size, obtaining
funding [18, 19], getting approval from the Research
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Ethics Committee (REC) [20–22], enrolling enough pa-
tients [23], performing appropriate statistical analyses [11]
and writing up and publishing the findings [19, 24, 25].
Among discontinued clinical studies, four out of ten were
not started because of lack of funding [26] and three out
of ten were abandoned because of insufficient patient en-
rollment [26]. For randomized clinical trials, the ability to
recruit patients during the first months after their initi-
ation is a strong indicator for study completion and publi-
cation [25, 27]. Finally, getting the paper published in a
peer-reviewed journal is also difficult: a quarter of submit-
ted paper send up never being published [28].
While a number of aspects regarding study processes
and outcomes have been investigated [25, 27–34], such
as patient recruitment, completion rates, publication or
number of citations, less is known about possible
difficulties experienced during the course of a clinical
study. Previous studies have explored the general im-
pression of medical researchers about difficulties in re-
search [19, 26, 35], but not the recall of actual
difficulties experienced in the course of a specific study.
Surveying medical researchers on a specific and com-
pleted study can provide a more accurate recall of the
aspects of the research process that have actually been
troublesome. We conducted therefore a survey among
medical researchers of study protocols approved by a
Swiss REC to assess the frequencies and types of difficul-
ties experienced, and to examine factors associated with
the occurrence of difficulties.
Methods
Setting
We defined medical researchers as principal investiga-
tors (PIs) of study protocols approved by the REC of the
Geneva University Hospitals, Switzerland between Janu-
ary 1, 2001 and December 31, 2005. The Geneva Univer-
sity Hospitals is a single 1800-bed public teaching
hospital, covering the entire range of medical disciplines,
with eight sites across the Geneva region. About 1200
research protocols are currently signaled as ongoing by
the REC.
Study design and questionnaire
We conducted a cross-sectional survey among PIs of the
selected protocols. We sent them a self-administered on-
line questionnaire between November and December
2010, followed by two reminders. We asked PIs to an-
swer one questionnaire for each separate protocol ap-
proved by the REC, identified by its title. The
questionnaire had been pre-tested previously among of
12 medical researchers who were not part of the study.
We asked PIs to report if the study was completed (de-
fined as recruitment, data collection and analysis com-
pleted, whatever the study is published or not) or not
(ongoing or abandoned) and whether they had received
training in quantitative methods (none, continuing edu-
cation at the University level, or bachelor/master/PhD in
quantitative methods) at the time of the submission to
the REC. If the study was completed, we asked PIs to
state if they encountered any of 14 specific difficulties in
the course of research (Fig. 1) on the following scale of
difficulty: none, minor, medium, great, very great, or not
applicable. Based on a review of the literature, a group
of experts including methodologists (AGA, GH, SC, TA,
TVP) and biostatisticians (DSC and Dr. Christophe
Combescure, see acknowledgements) identified these 14
difficulties in conducting clinical research. The results
from the pre-test with medical researchers suggested the
difficulties were clearly described. “Other difficulties”
could be reported in a fifteenth item as free text. We did
not invite PIs to rate their difficulties with ongoing stud-
ies, as we wanted to include only hindsight evaluations
of experience. We also asked PIs whether the results of
the study were published or “in press”, to provide the
reference in an open field, and also whether they had pa-
pers in submission or in preparation; for the latter stud-
ies, we updated the database by identifying relevant
papers published up to November 2013 (PubMed
search).
We identified characteristics of study protocols using
information recorded in the archives of the REC. We
abstracted data on study design (interventional, observa-
tional), first decision of the REC (positive, positive with
recommendations, positive with written modifications
required, positive with conditions and reassessment,
negative, and not considered), public vs. private sponsor-
ship of the study (i.e. hospital or university vs. industry
or private foundation), link with the industry (none, in-
dustry with indication of support, industry without indi-
cation of support), planned sample size (later
dichotomized as up to 100 vs. larger), reporting of sam-
ple size calculation (yes, no), number of centers (single
versus multi center), clinical specialty (oncology, neur-
ology, infectious disease, rheumatology, psychiatry, car-
diology, general, other specialties, combination of two
specialties), and presence of a statistician on study team
(yes, no). The category “Other specialties” included all
other specialties distributed across the medical services
of the Geneva University Hospitals (65 medical services),
or studies with no clear clinical specialty. We classified
the type of research conducted into the following seven
groups: study of health or illness (i.e., organs, tissues,
cells, receptors, etc.), interventional or treatment, diag-
nosis, prognosis, public health or health economics or
opinions or perceptions, study methods, and other. We
also dichotomized this variable in study protocols
informing clinical questions (i.e., interventional/treat-
ment, diagnostic and prognostic studies) versus other
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types of research (i.e., studies of health/illness, public
health, study methods, and other).
Dependent variables
In the survey among PIs, each of the 14 items of self-
reported difficulties was dichotomized into medium,
great or very great difficulty (1) versus no or minor diffi-
culty (0). When PIs answered “not applicable”, the value
“0” (no difficulty) was assigned, because we considered
not applicable difficulties as an absence of difficulty. The
fifteenth item for “other difficulty(ies)” was followed by
an open field for description. Some free-text responses
from this item were similar to the other 14 difficulties
already defined. One co-author (SC) recoded the text re-
sponses into the pre-defined difficulties and another co-
author (TP) checked the recoding. Eight free-text re-
sponses were re-classified and 41 remained in the
“other” category.
Dichotomized self-reported difficulties were used to
calculate sums of difficulties for each study and then to
compare mean numbers of difficulties across study
characteristics.
We defined three dependent variables. The first was a
score summing all difficulties across the whole research
process. We then classified the 14 difficulties into di-
mensions using factor analysis with varimax rotation
(for a complete description, see Additional file 1:
Appendix 1). The analysis suggested two dimensions of
seven difficulties each: a dimension related to “scientific
difficulties” (literature review, research question, study
design, data management, data analysis, manuscript
writing, publication in a peer-reviewed journal) and a di-
mension related to “logistical difficulties” (approval by
the REC, getting funding, getting approval by safety
agencies, patient enrollment, data collection, collabor-
ation with caregivers for patient enrollment, recruiting
competent staff ). Dimension scores based on the sum of
corresponding items were the second and third
dependent variables. Both had adequate internal
consistency, with a Cronbach alpha coefficient of 0.83
for scientific difficulties and 0.73 for logistical
difficulties.
Sample size calculation
The analysis of difficulties encountered by researchers
was a secondary objective of this study. The primary ob-
jective of this study was concerned with publication of
clinical studies (manuscript in preparation) and sample
size was determined with regard to the primary object-
ive. However, a sample size of 400 protocols yielded the
following precision (exact 95 % confidence interval) in
the estimation of prevalence for a given difficulty: 5.0 %
(3.1 to 7.6 %), 10.0% (7.2 to 13.4 %), 20 % (16.2 to
24.3 %), 30% (25.5 to 34.8 %), and 40 % (35.2 to 45.0 %).




















Approval by the safety agencies








Data analysis and interpretation
Data collection
Patient enrollment
Fig. 1 Self-reported difficulties* (rated as medium or great or very great) in clinical research among principal investigators (N = 386)
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each would allow for the detection of a small effect size
(0.28) with an alpha of 0.05 and a power of 80 %.
Statistical analysis
The unit of analysis was the study protocol. We treated
the three dependent variables (sum of all difficulties,
sum of scientific difficulties and sum of logistical diffi-
culties) as continuous. We first compared the means
across the study characteristics using one-way ANOVA.
Then a linear regression model was constructed to pre-
dict the mean scores of difficulties using predictors that
were statistically significant in univariable analysis (at
p ≤ 0.05). We conducted all analyses with SPSS version
22.0 (IBM Corporation, Armonk, United States).
Results
Sample
Among the 996 study protocols, 588 questionnaires were
returned by the PIs (participation rate 59.0 %). Among
these 588 studies, 391 (66.5 %) were completed at the
time of the survey, 96 (16.3 %) were still ongoing and
101 (17.2 %) had been abandoned.
More than three of four completed protocols were
sponsored by a public institution, about two thirds were
published, a majority was single center studies, and
about half were observational studies (Table 1). The me-
dian of the sample sizes was 100 (mean 591, interquar-
tile range 260, range 1 to 25,000) and a majority of study
protocols did not report sample size calculation. Study
protocols reporting a sample size calculation had more
often a sample size above the median compared to study
protocols that did not (60.9 % versus 30.4 %, p-value
<0.001). Almost three protocols out of four did not have
a statistician in the study team. Most PIs reported train-
ing in quantitative methods – courses or continuing
education or a University degree –at the time of the
protocol submission to the REC.
For 408 study protocols the questionnaire was not
returned by the PI. Information on these 408 studies
was collected using their study protocol stored in the ar-
chives of the REC. More than seven of ten studies had
no statistician in the study team, around two third had
public funding, and the majority had no link with the in-
dustry, were single center studies, were unpublished and
had an interventional design (Additional file 1: Appendix
2). The median sample size was 100 (mean 973, inter-
quartile range 321, range 3 to 136,000) and a majority of
study protocols did not justify sample size. Compared
with included studies, studies with no questionnaire had
higher proportions of interventional studies, private
sponsorship, link with the industry and were more fre-
quently unpublished.
Difficulties in clinical research and associated study
characteristics
Levels of difficulties are reported in Fig. 1: patient enroll-
ment and data collection were the most frequently re-
ported. The mean number of difficulties was 2.8
(standard deviation (SD) 2.8, min 0, max 12); 26.4 % of
PIs reported no difficulty and 18.7 % reported one diffi-
culty only (Additional file 1: Appendix 3). The mean
number of scientific difficulties was 1.1 (SD 1.7, min 0,
max 7) and the mean number of logistical difficulties
was 1.6 (SD 1.6, min 0, max 7).
In univariable analysis, study protocols sponsored by a
public institution (hospital or University) and single cen-
ter studies encountered more difficulties overall and
more scientific difficulties in particular (Table 2). Com-
pared to interventional designs, observational designs
encountered more scientific difficulties, but fewer logis-
tical difficulties. The presence of a statistician in the
study team was associated with fewer scientific difficul-
ties. Study protocols informing clinical questions (i.e.,
interventional, diagnostic or prognostic studies) were as-
sociated with more logistical difficulties compared to
other types of research (studies of health/illness, public
health, study methods, etc.). The same applied to the
first REC decision: study protocols whose first REC deci-
sion either required an additional assessment or was
negative (including non-consideration) reported more
logistical difficulties compared to study protocols that
received a positive first decision.
In multivariable analysis, study design, first decision of
the REC and the presence of a statistician on the study
team were not associated with a higher number of diffi-
culties (Additional file 1: Appendix 5) while several risk
factors remained significantly associated. In a parsimoni-
ous model (Table 3), publicly sponsored and single cen-
ter studies were associated with more difficulties overall
and more scientific difficulties. Studies informing clinical
questions were associated with higher number of diffi-
culties overall and with more logistical difficulties.
Specific difficulties by risk factors
The three study characteristics from the above multivari-
ate model (private vs. public, multi vs. single center and
“clinical” vs. other) were cross-tabulated with specific
difficulties (Table 4). Compared to publicly sponsored
studies, studies initiated by a private sponsor experi-
enced fewer difficulties with the research question, study
design, obtaining funding, data management, data ana-
lysis and interpretation, manuscript writing, and publica-
tion in a peer-reviewed journal. Similar results were
observed when multi center studies were compared to
single-center studies. Publicly sponsored studies and
single center studies experienced fewer difficulties
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concerning the approval by safety agencies, however
more difficulty with getting approval from the REC.
Furthermore, studies informing clinical questions re-
ported more difficulties with approval by safety agencies
or with patient enrollment. Non-clinical studies reported
more difficulties with the formulation of the research
question.
Discussion
The present study describes difficulties experienced in
the course of a specific study by a broad sample of med-
ical researchers at a Swiss university hospital. The main
finding is that patient enrollment posed a significant dif-
ficulty to 44 % of study protocols, and data collection
posed difficulty to 27 % of them. In other words, logis-
tical aspects of the research process seem to be the
major sources of problems in medical research. In con-
trast, formulating the research question and performing
the literature review were less likely to be an issue for
medical researchers. Across the whole research process,
medical researchers experienced on average three (2.8)
of 14 difficulties and only one out of four reported no
difficulty at all in conducting their study.
In a previous study investigating perceived barriers in
general, a majority of medical researchers reported numer-
ous obstacles in conducting research [19]. We found lower
prevalence rates, probably because we assessed difficulties
in a given study, and not over the career of a researcher.
Furthermore, we only included completed studies, which
did therefore not encounter a “fatal” problem.
The correlations between 14 types of difficulties sug-
gested two distinct dimensions: first, problems with the
logistics of a study, from funding to patient enrollment
and research personnel issues; second, scientific prob-
lems. Thus, different kinds of interventions are probably






First decision of the research ethics committee (N = 390)
Positive, positive with recommendations, or positive
with written modifications required
309 (79.2)
Positive with conditions and reassessment, or negative
and non-considered, but approved at a later stage
81 (20.8)
Financial sponsorship of the study protocol (N = 377)
Public (hospital, university) 294 (78.0)
Private (industry, foundation) 75 (19.9)
Both 8 (2.1)
Link with the industry (N = 378)
None 267 (70.6)
Industry with indication of support (funding, drugs,
human resources)
103 (27.2)
Industry without indication of support 8 (2.1)
Sample size (N = 390)
≤ 100 220 (56.4)
> 100 170 (43.6)







Health or illness (organs, tissues, cells, receptors, etc.) 91 (23.3)
Intervention or treatment 172 (44.0)
Diagnostics method 25 (6.4)
Prognosis 12 (3.1)
Public health, health economics, medical ethic, attitudes 43 (11.0)
Research methods (questionnaires, indicators,
measures, etc.)
41 (10.5)








Infectious diseases 27 (6.9)
Neurology 16 (4.1)
Rheumatology 7 (1.8)
Other clinical specialties 149 (38.1)
Table 1 Characteristics of the 391 completed studies with
follow-up questionnaire returned (Continued)
Two or more specialties 27 (6.9)
Presence of a statistician in the study team (N = 384)
Yes 98 (25.5)
No 286 (74.5)
PI’s training in quantitative methods
None 164 (41.9)
Courses and/or continuing education at the
University level
183 (46.8)
Bachelor, master or PhD in quantitative methods 8 (2.0)
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Mean p-value Mean p-value Mean p-value
Study design .45 .002 .047
Interventional 2.7 0.9 1.8
Observational 2.9 1.4 1.4
First decision of the REC .25 .89 .022
Positive, positive with recommendations, positive with written modifications required 2.7 1.1 1.5
Positive with conditions and reassessment, negative/non-consideration 3.1 1.1 2.0
Origin of the study protocol <.001 <.001 .12
Public (hospital, University, etc.) 3.1 1.4 1.6
Private (industry, foundation) 1.6 0.2 1.3
Sample size .33 .092 .96
≤median (100) 2.9 1.3 1.6
>median 2.6 1.0 1.6
Number of centers <.001 <.001 .21
Single 3.2 1.5 1.7
Multicenter 2.1 0.6 1.5
Type of research .79 .084 .006
Clinical (intervention, diagnosis, prognosis) 2.8 1.0 1.8
Others (health/illness, public health/health economics, methods, other) 2.7 1.3 1.3
Self-reported trainings in quantitative methods .37 .16 .80
None 2.9 1.3 1.6
Any 2.7 1.0 1.6
Presence of a statistician on study team (N = 384) .086 <.001 .54
No 2.9 1.3 1.6
Yes 2.4 0.6 1.7
Study published .71 .90 .34
No 2.7 1.1 1.5
Yes 2.8 1.1 1.6
aSum of difficulties reported on the following items: literature review, research question, design, data management, data analysis, manuscript writing, and
publication in a peer-reviewed journal
bSum of difficulties reported on the following items: approval by the Research Ethic Committee, getting funding, approval by the safety agencies, patient
enrollment, data collection, collaboration with caregivers for patient enrollment, recruiting competent staff to conduct the study
Table 3 Multivariable linear regression of sum of difficulties in clinical research
All difficulties (15 items) Scientific difficulties (7 items) Logistical difficulties (7 items)
Study characteristics: Difference 95 % CI Difference 95 % CI Difference 95 % CI
Public sponsorshipa (vs. private) 1.3 0.4,2.1 0.9 0.4,1.3 0.4 -0.1,0.9
Single center study (vs. multicenter) 0.8 0.1,1.5 0.6 0.2,1.0 0.3 -0.1,0.7
“Clinical” studyb (vs. otherc) 0.7 0.0,1.3 0.1 -0.2,0.5 0.6 0.3,1.0
Difference = beta coefficients; CI = confidence interval
aPublic hospital, University
b Intervention or diagnosis or prognosis studies
chealth/illness, public health/health economics, methods, other
Cullati et al. BMC Medical Research Methodology  (2016) 16:50 Page 6 of 9
needed to facilitate the conduct of clinical research. Lo-
gistical problems could be alleviated by a core facility
that would provide administrative support, fund-raising
assistance, and qualified research associates. Scientific
problems could be solved by the provision of statistical
assistance and methodological training of clinical re-
searchers. Such interventions have been implemented
with success in other settings [36]. It should be noted
that such structures were set up only in 2007 at the hos-
pital under study, most likely too late to have any major
influence on the course of research protocols approved
between 2001 and 2005. The provision of statistical as-
sistance may also have various impacts on the number
of patients to enroll [37]: one the one hand, statistical
assistance could increase the sample size at the stage of
designing the study; on the other hand, statistical assist-
ance could help medical researchers determine the smal-
lest necessary sample size. Thus, it is uncertain whether
the provision of statistical assistance would reduce or in-
crease logistical problems. In our results (multivariable
model), a statistician in the team was not associated with
logistical difficulties.
Studies initiated by a public sponsor (hospital or univer-
sity) as well as single center studies were associated with
more difficulties compared to those with private sponsor
or those multi center: these associations were significant
for the overall and the scientific scores, but not for the lo-
gistical score. When the study protocol came from a pub-
lic sponsor and when it was a single center study, it is
more likely that the PI was in charge of most steps, from
conception to publication. In contrast, many of these tasks
are typically not conducted by hospital based PIs when
study protocols are initiated by the industry.
Investigators of studies addressing clinical questions
also encountered more logistical difficulties, probably
because they need to enroll and collect data from pa-
tients. Most often, patient recruitment is conducted in
parallel to the delivery of healthcare, thus requiring
complex and numerous interactions with healthcare pro-
viders. Although as many as 72 % of patients invited to
take part in a clinical study in our institution accept to
do so [38], a better coordination of projects enrolling
similar patients in parallel might facilitate recruitment.
Other challenges relate to the patients’ willingness to
participate, which will depend on personal factors (such
as level of education), but also on the attributes of the
study. As shown in a previous work, patients are more
willing to participate in studies that explicitly value
safety, convenience, appropriate oversight, and open
communication [39].











Difficulties with: % % p % % p % % p
Literature review (get relevant articles, read, synthesize) 2.4 6.9 0.19 3.1 7.9 0.078 7.2 4.9 0.39
Research question (formulation of a main research
question and/or hypothesis)
1.2 13.1 0.001 3.2 15.0 <0.001 15.1 5.9 0.004
Study design (identification of the study design, variables,
instruments, analysis, including calculation of the sample size)
2.4 25.8 <0.001 8.2 29.1 <0.001 23.3 18.0 0.21
Approval by the Research Ethics Committee 12.2 17.9 0.25 11.9 20.3 0.038 12.8 20.4 0.056
Getting funding 3.7 23.9 <0.001 13.8 23.1 0.026 19.0 19.5 1.00
Approval by the safety agencies (Swiss Agency for
Therapeutic Products, etc.)
17.3 8.3 0.023 14.6 7.0 0.024 3.9 15.7 <0.001
Patients enrollment 51.3 41.5 0.13 48.1 42.5 0.30 37.1 51.5 0.005
Data collection 19.5 28.9 0.12 22.0 30.0 0.10 26.1 27.2 0.82
Collaboration with caregivers for patient enrollment 18.3 22.1 0.54 20.1 21.8 0.80 19.4 22.5 0.53
Recruitment of competent persons to conduct the study 12.2 22.0 0.059 16.4 22.9 0.12 16.7 23.3 0.13
Data management 6.1 20.4 0.002 10.1 21.8 0.002 19.6 14.6 0.22
Data analysis (statistical or other) and results interpretation 3.7 26.7 <0.001 10.8 29.3 <0.001 23.5 20.1 0.46
Writing a manuscript for a scientific publication 1.2 23.8 <0.001 8.9 25.6 <0.001 20.9 16.7 0.36
Publication in a peer-reviewed journal 4.9 25.5 <0.001 14.6 24.8 0.020 21.1 20.0 0.80
Other(s) difficulty(ies) 3.7 5.8 0.58 5.0 5.3 1.00 8.9 1.9 0.002
aSelected from the multivariable model (Table 3). P-values come from the Fisher’s exact test
bIndustry or foundation
cHealth/illness, public health, methodology, etc
dIntervention or diagnosis or prognosis
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In contrast with other surveys [18, 19], we found that
getting funding did not represent a significant barrier in
conducting clinical research. Three explanations can be
considered: first, we surveyed medical researchers about
completed studies (which were all funded), while other
surveys assessed the general opinion of medical re-
searchers. Second, Switzerland is a relatively favorable
country for conducting research: between 2000 and
2008, the funding for research and development in-
creased from 2.5 % of the gross domestic product to
3.0 % [40]. Third, in some cases, clinical studies can be
conducted without external funding when benefiting
from non-financial support of the hospital.
Another result worth noting is the similarity in the
average number of difficulties encountered by PI trained
in quantitative methods compared to those not trained
in these methods. Training in quantitative methods
probably has limited impact on logistical issues; however
we expected an impact on scientific issues. It is possible
that trained investigators design and conduct more com-
plex or ambitious studies, thus facing a similar absolute
number of challenges, yet at a more advanced level.
More than one fourth (26.4 %) of study protocols were
conducted without difficulties. More research on these
study protocols, using qualitative methods, could add
evidence on the facilitating factors for conducting clin-
ical research.
Limitations
This study has several limitations. First, it was carried
out at a single Swiss university hospital and we do not
know to what extent the findings apply to other settings.
Second, we only surveyed PIs of completed clinical stud-
ies, which may have decreased the apparent prevalence
of major difficulties, because abandoned clinical studies
[25, 29] may have experienced more difficulties. Third,
PIs’ answers may have been affected by various recall
biases [38]. Social desirability may also have influenced
responses, considering that the investigators in charge of
the present study belong to the same institution as the
surveyed PIs. Fourth, the scale of difficulties (and the
two subscales, logistic and scientific difficulties) was
built for the purpose of this study, based on literature re-
view and expert consensus. We have no evidence of
their validity beyond face validity, though their reliability
was acceptable (Cronbach alpha between 0.73 and 0.83).
Moreover, among the 14 items composing the scale, four
items (getting funding, data collection, recruitment of
competent staff to conduct the study, and data manage-
ment) shared variance on both subscales (see Additional
file 1: Appendix 1). Fifth, the analysis of studies with no
questionnaire suggested some evidence for non-response
bias: undocumented studies were more frequently
interventional studies, with industry sponsorship, and
unpublished.
Conclusions
Patient enrollment and logistical problems topped the
list of difficulties. Clinical studies and single-center stud-
ies were at higher risk of experiencing logistical difficul-
ties. Providing both logistical and methodological
support to researchers may facilitate the conduct of re-
search projects.
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